Showing results (4481-4490 of 9,339) with videos related to

Sort By:
Pageof 934
Cancer Medicine|May 16, 2024
Cardiovascular adverse events associated with immune checkpoint inhibitors: A retrospective multicenter cohort studyYi Zheng, Ziliang Chen, Wenhua Song, et al.
Cancer Medicine|May 8, 2024
Regorafenib with immunotherapy versus regorafenib alone as second-line treatment for hepatocellular carcinoma: A multicenter real-world studyLiang Qiao, Wei He, Guoying Wang, et al.
Cancer Medicine|May 7, 2024
Comparative analysis of genetic testing utilization rates among people with and without disabilities in South Korea from 2016 to 2019, focusing on malignant neoplasms: A national population-based studyGwanwook Bang, Minji Park, Jeong-Yeon Seon, et al.
Cancer Medicine|May 8, 2024
Neoadjuvant immunotherapy improves outcomes for resectable gastroesophageal junction cancer: A systematic review and meta-analysisDanzhu Wu, Liyuan Yang, Yu Yan, et al.
Cancer Medicine|April 25, 2024
The efficiency and safety of low-dose apatinib combined with oral vinorelbine in pretreated HER2-negative metastatic breast cancerJia-Yi Huang, Xue-Lian Chen, Xiao-Feng Xie, et al.
Cancer Medicine|April 25, 2024
Could nutrition status predict fatigue one week before in patients with nasopharynx cancer undergoing radiotherapy?Jihong Song, Xinru Yang, Jieling Wu, et al.
Cancer Medicine|April 25, 2024
α-Hederin induces paraptosis by targeting GPCRs to activate Ca2+/MAPK signaling pathway in colorectal cancerXiwu Rao, Ziwen Li, Qinchang Zhang, et al.
Cancer Medicine|April 23, 2024
Flow cytometric minimal residual disease measurement accounting for cytogenetics in children with non-high-risk acute lymphoblastic leukemia treated according to the ALL-MB 2008 protocolAlexander Popov, Guenter Henze, Grigory Tsaur, et al.
Cancer Medicine|April 23, 2024
PD-1 inhibition with retifanlimab and/or arginase inhibition with INCB001158 in Japanese patients with solid tumors: A phase I studyYasutoshi Kuboki, Takafumi Koyama, Nobuaki Matsubara, et al.
Cancer Medicine|April 29, 2024
Benefits and risks of clofarabine in adult acute lymphoblastic leukemia investigated in depth by multi-state modelingSjoerd J F Hermans, Yvette van Norden, Jurjen Versluis, et al.
Pageof 934